Edit
Gemphire Therapeutics
http://www.gemphire.com/Last activity: 03.09.2015
Active - Reference to NeuroBo Pharmaceuticals, Inc.
Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing gemcabene for the treatment of dyslipidemia.
Status: Acquired by NeuroBo Pharmaceuticals in 2019
Status: Acquired by NeuroBo Pharmaceuticals in 2019
Location: United States, Michigan, Ann Arbor
Total raised: $2.8M
Investors 1
| Date | Name | Website |
| - | Excel Vent... | excelvm.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.09.2015 | - | $2.8M | - |
Mentions in press and media 1
| Date | Title | Description |
| 03.09.2015 | Gemphire Therapeutics Closes $2.8M Financing | Gemphire Therapeutics, a Northville, Michigan-based developer of LDL-cholesterol lowering drug gemcabene, closed a $2.8m convertible bridge financing. Backers included Grand Angels and existing angel investors and local funds. The company w... |